Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Kurosu has a long-term interest in development of new antibacterial agents targeting novel or unexploited drug targets. In order to develop novel antibacterial molecules, he develops concise syntheses of relatively complex molecules, and designs chiral molecules and generates small optimized libraries. He also develops convenient assays against target enzymes of interest. These efforts have resulted in the discovery of several new drug leads effective against MDR-Gram-positive pathogens including MDR-M. tuberculosis. Over the last 10 years, he has studied electron transport system, menaquinone biosynthesis, unexploited peptidoglycan biosynthesis, and bacterial kinases.
Synthesis and Biological Evaluation of Biologically Active Natural Products, Rational drug design, bioorganic chemistry, Development of Enzymatic Assays of Small Molecules, and New Chemical Tools.
NetworkAmgad Mohammed Rabie Hamed Fouda has completed his MSc and Postgraduate studies in Pharmaceutical and Biomedical Sciences at the age of 30 years from the Faculty of Pharmacy, Mansoura University, Egypt. He is one of the most famous and reputed Egyptian and Arab pharmacists, researchers and scientists. His new researches focused on the synthesis, discovery, and development of new drugs and medicines for the most resistant and untreated human diseases. He is the head of pharmacists at the Dikernis General Hospital (Mansoura, Egypt), a premier governmental hospital in Egypt. He has published 46 papers in very reputed journals and serving as an Editorial Board Member of great repute.
Pharmaceutical Organic/Medicinal Chemistry, Drug Design/Discovery, Pharmaceutical/Medical Sciences, Clinical Medical Research
NetworkMake the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals